Multi-Omics Core C
多组学核心 C
基本信息
- 批准号:10555124
- 负责人:
- 金额:$ 34.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-15 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:16S ribosomal RNA sequencingATAC-seqAcetylationAddressAdultAnimalsApplications GrantsBasic ScienceBioinformaticsBiometryCell NucleusCellsChromatinChromatin StructureClinicalCost SavingsDNADNA MethylationDNA Sequencing FacilityDataData AnalysesData CollectionDepositionEnsureEnvironmentExperimental DesignsGenesGenomicsGoalsHistone DeacetylaseHumanInstitutionKidneyLifeLinkLiquid ChromatographyLysineMass Spectrum AnalysisMediatingMethodsPreparationProteinsProteomicsProtocols documentationQuality ControlRNAReagentRegulationReproducibilityResolutionRiskRisk FactorsRodentSamplingStandardizationStructureTechniquesTechnologyTestingTissuesTranscriptional RegulationVolatile Fatty AcidsWorkbench to bedsidecardiovascular disorder riskdata managementdata submissionearly life stressepigenetic regulationepigenomeepigenomicsexperienceexperimental studygenome-wide analysisgut microbiomeinnovationinnovative technologiesmembermetabolomemetabolomicsmethylomemicrobialmicrobiomemicrobiome researchmultiple omicsnew technologyrepositoryresiliencesample collectionsingle nucleus RNA-sequencingsynergismtandem mass spectrometrytechnology platformtranscriptometranscriptome sequencingtranscriptomics
项目摘要
MULTI-OMICS CORE C SUMMARY
This PPG is addressing an important hypothesis that early life stress (ELS) leads to reprogramming throughout
the body resulting in an increased risk of developing CVD in adulthood. The mechanistic links between ELS and
CVD and resilience in adulthood is not established. Epigenetic regulation of transcription or the gut microbiome
and microbial-derived factors are hypothesized to be sensitive to ELS and may be modifiable to mediate
resiliency. The primary goal and function of the Multi-omics Core (Core C) is to provide start-of-the-art processing
of samples for determination of transcriptomes, DNA methylomes, DNA chromatin accessibility, metabolomes,
and microbiomes required by all Projects. The objective of the Core is to provide consistency and rigor in the
multi-omics experiments and provide innovative technologies to meet the goals of the Projects. The specific aims
of Core C are: Aim 1 Transcriptomic and epigenomic determination. The epigenome is an important
connection between the environment and the genes expressed in each cell (transcriptomes) and it is regulated
by DNA methylation and chromatin structure (accessibility). Core C will facilitate determination of transcriptomes,
and epigenome global DNA methylation and chromatin accessibility for the Projects. Aim 2: Microbiome and
metabolite profiling. In this PPG, it is hypothesized that ELS results in gut microbial diversity changes that
result in significant alterations to circulating short chain fatty acids (SCFA) or other metabolites. Core C will
prepare samples for microbiome 16S sequencing for identifying and quantifying microbial diversity. The Core
will also prepare samples for SCFA and untargeted metabolite determination by mass spectrometry. Aim 3:
Evaluating new technologies, optimization while promoting fiscal responsibility. In this era of multi-omics,
technologies are rapidly evolving. Thus, to provide the Projects with the latest technologies to test their
hypotheses, Core C will evaluate new technological platforms. Core C will optimize all protocols for sample
preparation for the multi-omics approaches listed above. By centralizing the mutli-omic sample preparation in
Core C, we will purchase kits and reagents in bulk leading to substantial cost savings. Core C will interact directly
with all Projects, receive clinical samples from Core B, and work directly with Core A for sample identification,
curating, data deposition and analyses, and data management. Core A will complete all bioinformatics and
biostatistical analyses for data generated in Core C. The approaches used in Core C ensure that the PPG is
using the latest technologies for determining mechanisms of ELS induced cardiovascular disease risk with a
bench to beside approach.
多词核心C摘要
该PPG正在解决一个重要的假设,即早期生活压力(ELS)导致整个过程中重新编程
身体导致成年后发生CVD的风险增加。 EL和EL之间的机械联系
CVD和成年期间的弹性尚未确定。转录或肠道微生物组的表观遗传调节
假设微生物衍生的因素对EL敏感,并且可以修改以介导
弹性。多摩斯核心(核心C)的主要目标和功能是提供启动处理
用于测定转录组,DNA甲基组,DNA染色质可及性,代谢组,代谢组的样品的样品
和所有项目都需要的微生物组。核心的目的是在
多派对实验并提供创新的技术来满足项目的目标。具体目标
核心的C为:AIM 1转录组和表观基因组学测定。表观基因组很重要
环境与每个细胞中表达的基因之间的连接(转录组),并受到调节
通过DNA甲基化和染色质结构(可访问性)。核心C将促进转录组的确定,
以及这些项目的表观基因组全球DNA甲基化和染色质的可及性。目标2:微生物组和
代谢物分析。在此PPG中,假设EL会导致肠道微生物多样性变化,
导致循环短链脂肪酸(SCFA)或其他代谢产物的重大改变。 Core C Will
准备微生物组16S测序的样品,以识别和量化微生物多样性。核心
还将通过质谱法制备用于SCFA和非靶向代谢物测定的样品。目标3:
评估新技术,优化,同时促进财政责任。在这个多词时代,
技术正在迅速发展。因此,为项目提供最新技术来测试他们的
假设Core C将评估新的技术平台。核心C将优化样本的所有协议
准备上面列出的多词方法的准备。通过将utli-omic样品制备集中在
Core C,我们将大量购买套件和试剂,从而节省大量成本。核心C将直接相互作用
在所有项目中,从Core B接收临床样本,并直接与Core A合作以进行样本识别,
策划,数据沉积和分析以及数据管理。核心A将完成所有生物信息学和
对核心C中生成的数据的生物统计分析。核心C中使用的方法确保PPG为
使用最新技术来确定EL诱导心血管疾病风险的机制
长凳在接近旁边。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelly Hyndman其他文献
Kelly Hyndman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelly Hyndman', 18)}}的其他基金
Deep South KUH Premier Research- Interdisciplinary Mentored Education (PRIME) Networking Core
深南 KUH 顶级研究 - 跨学科指导教育 (PRIME) 网络核心
- 批准号:
10724929 - 财政年份:2023
- 资助金额:
$ 34.63万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10445263 - 财政年份:2021
- 资助金额:
$ 34.63万 - 项目类别:
Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
- 批准号:
10295288 - 财政年份:2021
- 资助金额:
$ 34.63万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10175553 - 财政年份:2021
- 资助金额:
$ 34.63万 - 项目类别:
Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
- 批准号:
10625369 - 财政年份:2021
- 资助金额:
$ 34.63万 - 项目类别:
Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
- 批准号:
10413226 - 财政年份:2021
- 资助金额:
$ 34.63万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10662292 - 财政年份:2021
- 资助金额:
$ 34.63万 - 项目类别:
Novel mechanisms of HDAC1 regulation of renal collecting duct function
HDAC1调节肾集合管功能的新机制
- 批准号:
8868322 - 财政年份:2015
- 资助金额:
$ 34.63万 - 项目类别:
Novel mechanisms of HDAC1 regulation of renal collecting duct function
HDAC1调节肾集合管功能的新机制
- 批准号:
9766242 - 财政年份:2015
- 资助金额:
$ 34.63万 - 项目类别:
相似国自然基金
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:82260745
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:32100438
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Combined bromodomain and CDK4/6 inhibition in NUT Carcinoma and other solid tumors
溴结构域和 CDK4/6 联合抑制 NUT 癌和其他实体瘤
- 批准号:
10577265 - 财政年份:2023
- 资助金额:
$ 34.63万 - 项目类别:
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
- 批准号:
10752404 - 财政年份:2023
- 资助金额:
$ 34.63万 - 项目类别:
PBRM1 bromodomain missense mutations in ccRCC vascular signaling
ccRCC 血管信号传导中的 PBRM1 溴结构域错义突变
- 批准号:
10604440 - 财政年份:2023
- 资助金额:
$ 34.63万 - 项目类别: